Molecular Effects of Topical Calcipotriene on Morphea

NCT02411643 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Accrual incomplete/Investigator left institution

Conditions

Morphea
Localized Scleroderma

Interventions

DRUG: topical calcipotriene 0.005% ointment

Sponsor

Northwestern University